Hinkle, Gregory,Sepp-Lorenzino, Laura,Jadhav, Vasant,Maier, Martin,Milstein, Stuart,Manoharan, Muthiah,Rajeev, Kallanthottathil G.
申请号：
HRP20192177
公开号：
HRP20192177T1
申请日:
2019.12.02
申请国别(地区):
HR
年份:
2020
代理人:
摘要：
The present invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the hepatitis B virus (HBV) genome, and methods of using such RNAi agents to inhibit expression of one or more HBV genes and methods of treating subjects having an HBV infection and/or HBV-associated disorder, e.g., chronic hepatitis B infection.
